Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
EMT-6 murine mammary tumors were made resistant to cis-diamminedichloroplatinum (II) (CDDP), carboplatin, cyclophosphamide (CTX), or thiotepa in vivo by treatment of tumor-bearing animals with the drug during a 6-month period. In spite of high levels of in vivo resistance, no significant resistance was observed when the cells from these tumors were exposed to the drugs in vitro. The pharmacokinetics of CDDP and CTX were altered in animals bearing the respective resistant tumors. The resistance of all tumor lines except for the EMT-6/thiotepa decreased during 3 to 6 months in vivo passage in the absence of drugs. These results indicate that very high levels of resistance to anticancer drugs can develop through mechanisms that are expressed only in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo studies have demonstrated that tumors exposed to repeated alkylating agent treatment in murine models developed significant resistance, which was not observed when the same cells were cultured in vitro, underscoring the essential role of stromal interactions in modulating therapeutic response [146].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [146]
Citations
Cites
Ellman, G. L. (1959) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(59)90090-6 · Cited by 26,311
Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent
Sedlak, J., & Lindsay, R. H. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90092-4 · Cited by 8,077
Teicher, B. A., Lazo, J. S., & Sartorelli, A. C. (1981) · PubMed · Cited by 555
Self-citationThe genetic origin of drug resistance in neoplasms: implications for systemic therapy.
Goldie, J. H., & Coldman, A. J. (1984) · PubMed · Cited by 511
A fluorometric assay for glutathione
Cohn, V. H., & Lyle, J. (1966) · Analytical Biochemistry · doi:10.1016/0003-2697(66)90286-7 · Cited by 441
(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/49.3.735 · Cited by 397
Presence of a growth-stimulating factor in serum following primary tumor removal in mice.
Fisher, B., Gündüz, N., Coyle, J., Rudock, C., & Saffer, E. (1989) · PubMed · Cited by 361
Teicher, B. A., Holden, S. A., Kelley, M. J., Shea, T. C., Cucchi, C. A., Rosowsky, A., Henner, W. D., & Frei, E. (1987) · PubMed · Cited by 312
Self-citationTherapeutic attack of hypoxic cells of solid tumors: presidential address.
Sartorelli, A. C. (1988) · PubMed · Cited by 278
Chapter 15 Serial Cultivation of Normal Human Epidermal Keratinocytes
Rheinwald, J. G. (1980) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)60769-4 · Cited by 264
Research works printed but not linked: 9
- COHEN, V.H., ANAL BIOCHEM 14: 434 (1986).
- FREI, E, MECHANISMS DRUG RESI 69 (1988).
- HERMAN, T.S., EFFECT OF HYPERTHERMIA ON THE ACTION OF CIS-DIAMMINEDICHLOROPLATINUM(II), RHODAMINE 1232 [TETRACHLOROPLATINUM(II)], RHODAMINE 123, AND POTASSIUM TETRACHLOROPLATINATE INVITRO AND INVIVO, CANCER RESEARCH 48: 2335 (1988).
- ODELL, W.D., ADV INTERNAL MED 34: 325 (1989).
- ROCKWELL, S, CYTOTOXIC AND RADIOSENSITIZING EFFECTS OF HYPOXIC CELL SENSITIZERS ON EMT6 MOUSE MAMMARY-TUMOR CELLS INVIVO AND INVITRO, BRITISH JOURNAL OF CANCER 37: 212 (1978).
- ROCKWELL, S, INVIVO-INVITRO TUMOR SYSTEMS - NEW MODELS FOR STUDYING RESPONSE OF TUMORS TO THERAPY, LABORATORY ANIMAL SCIENCE 27: 831 (1977).
- SARTORELLI, A.C., CANCER RES 48: 775 (1988).
- SCHABEL, F.M., PHARMACOL THERAPEUT 20: 282 (1983).
- TEICHER, B.A., DRUG RESISTANCE MAMM 2: 1 (1988).
Cited by
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
Browder, T. D., Butterfield, C., Kräling, B. M., Shi, B., Marshall, B., OʼReilly, M., & Folkman, J. (2000) · PubMed · Cited by 1,720
Ovarian cancer: strategies for overcoming resistance to chemotherapy
Agarwal, R., & Kaye, S. B. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1123 · Cited by 1,154
Metadata
- Authors
- Teicher, B., Herman, T., Holden, S., Wang, Y., Pfeffer, M., Crawford, J., & Frei, E.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Venue
- Science
- Published
- 1990-03-23
- Volume
- 247
- Issue
- 4949
- Pages
- 1457-1461
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1983075270
- Cited by
- 327
- References
- 39
- Citations by year
- 2026: 2 · 2025: 5 · 2023: 5 · 2022: 5 · 2021: 2 · 2020: 6 · 2019: 7 · 2018: 9 · 2017: 14 · 2016: 11 · 2015: 10 · 2014: 13 · 2013: 8 · 2012: 10
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1p01ca038497-01)
- National Cancer Institute (P01-CA 38497)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Keywords
- alkylating agent resistance, cisplatin resistance, carboplatin, cyclophosphamide, thiotepa, pharmacokinetics, tumor-bearing animals, drug resistance reversal
- MeSH terms
- Alkylating Agents, Animals, Antineoplastic Agents, Cisplatin, Cyclophosphamide, Drug Resistance, Kidney, Liver, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Organoplatinum Compounds, Sulfhydryl Compounds, Thiotepa, Tissue Distribution, Tumor Cells, Cultured, Carboplatin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. https://app.cochat.ai/papers/10.1126/science.247.4949.1457
- The paper
- Teicher, B., Herman, T., Holden, S., Wang, Y., Pfeffer, M., Crawford, J., & Frei, E. (1990). Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science. https://doi.org/10.1126/science.247.4949.1457
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.